Evaluation of Infigratinib in Patients With Locally Advanced or Metastatic Gastric Cancer or GEJ Adenocarcinoma
Clinical trial NCT06206278 · TERMINATED
Trial details
- NCT number
- NCT06206278
- Sponsor
- LianBio LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-19
- Primary completion
- 2024-05-31
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.